Search

Search Constraints

You searched for: Author/Creator Papavassilis, Charis

Search Results

2. Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients. Issue 6 (11th July 2018)

3. Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75–89 response: results from two phase 3 studies of secukinumab. (18th August 2017)

4. Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis. (30th October 2015)

6. Secukinumab efficacy and safety in Japanese patients with moderate‐to‐severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo‐controlled, phase 3 study. Issue 12 (30th October 2014)

7. Secukinumab improves patient‐reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo‐controlled clinical trials. (11th February 2016)

8. Secukinumab Provides Clearer Skin and Better Control on Patient-Reported Psoriasis Symptoms of Itching, Pain, and Scaling than Placebo and Etanercept. Issue 4 (September 2016)